XML 78 R65.htm IDEA: XBRL DOCUMENT v3.5.0.2
Business Combinations and Contingent Consideration - Summary of Allocation of Total Purchase Price to Net Assets Acquired (Detail) - Captisol-enabled, propylene glycol-free melphalan rights [Member] - USD ($)
$ in Thousands
Jun. 30, 2016
Mar. 31, 2013
Business Acquisition, Contingent Consideration [Line Items]    
Total purchase consideration   $ 7,700
In-process research and development [Member]    
Business Acquisition, Contingent Consideration [Line Items]    
Total purchase consideration $ 7,700